Type 2 diabetes (T2D) is a major risk factor for late-onset Alzheimer's disease (AD). A variety of metabolic changes related to T2D (e.g. hyperinsulinemia, hyperglycemia, and elevated branched-chain amino acids) have been proposed as mechanistic links, but the basis for this association remains unknown. Retromer-dependent trafficking is implicated in the pathogenesis of AD, and two key retromer proteins, VPS35 and VPS26, are deficient in the hippocampal formation of AD patients. We characterized VPS35 levels in five different mouse models of T2D/ obesity to identify specific metabolic factors that could affect retromer levels in the brain. Mouse models in which hyperleucinemia was present displayed hippocampus-selective retromer deficiency. Wild-type lean mice fed a high leucine diet also developed hippocampal-selective retromer deficiency, and neuronal-like cells grown in high ambient leucine had reduced retromer complex proteins. Our results suggest that hyperleucinemia may account, in part, for the association of insulin resistance/T2D with AD.
Introduction
Although late-onset Alzheimer's disease (AD) is a pathogenically complex disorder, recent findings have implicated a few unifying mechanisms (Tosto and Reitz, 2013) . One of these is endosomal trafficking, in which retromer-dependent transport plays a key role (Gandy and DeKosky, 2013; Siegenthaler and Rajendran, 2012) . The retromer, a coat-like complex that traffics cargo out of endosomes, is composed of two functionally distinct subcomplexes. The first is a trimeric complex comprising Vacuolar Protein Sorting 35 (VPS35), VPS26, and VPS29, the core of the retromer that binds cargo at the endosomal membrane. The second is a membrane-associated subcomplex made up of different sorting nexins (SNX 1, 2, 3, 5, 6, or 27) (Bonifacino and Hurley, 2008) .
Retromer-dependent trafficking is implicated in late onset AD. Both VPS35 and VPS26 are reduced by approximately 40% in the hippocampal formation of late-onset AD patients (Small et al., 2005) .
Genetically-engineered animal models with an equivalent deficiency in hippocampal VPS35 and VPS26 show a loss of retromer function and phenocopy features of AD (Muhammad et al., 2008) . Allelic variations in genes that cause dysfunction in retromer-dependent trafficking (e.g. SORL1) have also been linked to AD (Rogaeva et al., 2007; Vardarajan et al., 2012) .
Type 2 diabetes (T2D) and AD are associated epidemiologically (Luchsinger et al., 2001) , specifically via T2D-associated phenotypes such as hyperinsulinemia, hyperglycemia, and obesity (Luchsinger, 2008) . Increased circulating concentrations of branched chain amino acids (BCAAs: leucine, isoleucine, valine), which are also associated with insulin resistance and obesity (Adams, 2011; Newgard, 2012; Ridaura et al., 2013; She et al., 2007) , are an early biomarker/risk factor for T2D (Wang et al., 2011) . However, these complex metabolic phenotypes of T2D render mechanistic analysis of this association difficult. Recent studies have implicated elements of the retromer pathway in T2D, raising the possibility that AD and T2D share a common molecular pathogenic mechanism (Lane et al., 2012) . We asked a simple question: Among the many metabolic abnormalities that characterize T2D, do any specifically cause retromer deficiency in the hippocampal formation? To address this question, we screened mouse models of T2D/obesity for alterations in brain retromer levels to identify a shared factor, which was then validated by performing interventional studies in mice and in neuronal cell cultures. E-mail address: sas68@columbia.edu (S.A. Small). Available online on ScienceDirect (www.sciencedirect.com). 1 These authors contributed equally to this work.
